Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges
As a ubiquitous human pathogen, the Epstein–Barr virus (EBV) has established lifelong persistent infection in about 95% of the adult population. The EBV infection is associated with approximately 200,000 human cancer cases and 140,000 deaths per year. The presence of EBV in tumor cells provides a un...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2025-01-01
|
| Saila: | Viruses |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/1999-4915/17/1/110 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|